from Health and Quality of Life Outcomes at http://bit.ly/2JTgFVo on May 31, 2019 at 10:36PM Adverse events (AEs) are common during treatment of drug-resistant tuberculosis (DR-TB). Little is known about the health-related quality of life (HRQoL) of patients receiving treatment for DR-TB or the effect…
from Google Alert at http://bit.ly/2WvvLX6 on May 31, 2019 at 09:47PM With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including …
from Amanda Glassman at http://bit.ly/2MkhkRO on May 31, 2019 at 09:36PM After 2020: What’s Next for Global Access to Family Planning Publication 5/31/19 Next week, Women Deliver—the world’s largest conference on gender equality and the health, rights, and wellbeing of women and girls—will kick off. This note highlights three issues for the global FP movement post-2020. We […]
from AcademyHealth Blog at http://bit.ly/2IfsCRR on May 31, 2019 at 09:29PM AcademyHealth CEO Details How Determinants and Data Are Creating Delivery Improvements In a Health Affairs blog post published today, Dr. Simpson discusses a shift in the focus to social determinants of health, noting both the progress and opportunities in this area. She also highlights […]
from Google Alert at http://bit.ly/2MzWNZN on May 31, 2019 at 06:29PM Huntsworth has also purchased 70% of CC, a strategic market access, health economics and outcomes research consultancy in Luxembourg, …
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2YX0FVL on May 31, 2019 at 05:02PM COTA and the Food and Drug Administration (FDA) have partnered to utilize real-world evidence to generate new insight into the treatment of cancer, BioSpace reports. The two-year partnership looks to develop a new study protocol, according to the report, and will […]
from Social Science & Medicine at http://bit.ly/2IaKPQM on May 31, 2019 at 04:40PM Publication date: Available online 31 May 2019 Source: Social Science & Medicine Author(s): Robin A. Richardson, Sam Harper, Lisa M. Bates, Arijit Nandi Abstract Agency, the ability to identify goals and then act upon them, is a core component of women’s empowerment […]
from Social Science & Medicine at http://bit.ly/2WgWKGC on May 31, 2019 at 04:40PM Publication date: Available online 30 May 2019 Source: Social Science & Medicine Author(s): Takashi Oshio, Mari Kan
from Health Policy at http://bit.ly/2KfmxaV on May 31, 2019 at 04:40PM Publication date: Available online 30 May 2019 Source: Health Policy Author(s): Aldona Frączkiewicz-Wronka, Iwona Kowalska-Bobko, Anna Sagan, Martyna Wronka-Pośpiech Abstract Seniors Councils are advisory and consultative bodies that support local political decision-making to assure that the views of older people are taken into account […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Wg3PqQ on May 31, 2019 at 04:32PM The Academy of Managed Care Pharmacy (AMCP) is seeking input on the latest draft of its format for manufacturer-payer communications as it looks to align it with the Food and Drug Administration’s guidance, “Drug and Device Manufacturer Communications with Payors, Formulary […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2IczY8J on May 31, 2019 at 04:32PM Evidera on Thursday, May 30, announced the acquisition of Medimix International, a global tech company that uses real-world evidence to generate insights into the pharmaceutical, diagnostic and medical device industries. According to a press release, the arrangement will allow Evidera to […]
from The Health Care Blog at http://bit.ly/30UY5lb on May 31, 2019 at 04:28PM By SAURABH JHA, MD What does it take to create a decision rule? In this episode of Radiology Firing Line podcast Saurabh Jha (@RogueRad) has a discussion with Robert W. Yeh MD MBA about the deep thought and complex statistics involved in […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2wxF4qI on May 31, 2019 at 04:02PM New research by a team at Harvard Medical School’s Program on Regulation, Therapeutics and Law suggests that drugs with accelerated approval status generally fail to show clear benefits after follow-up trials, NPR reports. Researchers took a deep dive into a 2018 […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2Z3AFIz on May 31, 2019 at 04:02PM New Zealand this week approved a new “well-being budget” aimed at bolstering mental health services and combating child poverty, the Associated Press reports. The budget includes roughly $1.2 billion for mental health care over the next four years. The funds will […]
from Google Alert at http://bit.ly/2Xiu7Fo on May 31, 2019 at 03:17PM Health Economics Market Report offers comprehensive insight, industry knowledge, market forecasts, and analytics. The report thoroughly explains …
from Value in Health at http://bit.ly/2YWQwsb on May 31, 2019 at 11:27AM Publication date: Available online 31 May 2019 Source: Value in Health Author(s):
from Value in Health at http://bit.ly/2wwiOgY on May 31, 2019 at 11:27AM Publication date: Available online 31 May 2019 Source: Value in Health Author(s): Jorge Caro-Bautista, Milagrosa Espinar-Toledo, Francisca Villa-Estrada, Inmaculada Lupiáñez-Pérez, Shakira Kaknani-Uttumchandani, Silvia García-Mayor, Felipe Salas-Samper, José-Miguel Morales-Asencio Abstract Background Several instruments are available to evaluate barriers to self-care in people with type […]
from Market Design at http://bit.ly/2HMRKAy on May 31, 2019 at 11:00AM The recent death of Dr. Leonard Bailey (who performed the first successful heart transplant to an infant) reminded me of how so many ultimately successful stories in organ transplantation begin with rather wild shots in the dark, involving patients who have little to lose. […]
from Health Economics Review at http://bit.ly/2wup2OD on May 31, 2019 at 11:00AM The incidence of Achilles tendon rupture in the UK is increasing and the best rehabilitation strategy for patients treated non-operatively remains unclear. We describe a statistical analysis plan (SAP) for the…
from Health Economics Review at http://bit.ly/2YZ7DJP on May 31, 2019 at 11:00AM Mild cognitive impairment (MCI) is defined as a decline in cognitive state with preservation of activities of daily living. Medications such as donepezil and rivastigmine have been commonly prescribed for MCI,…
from Health Economics Review at http://bit.ly/2wup1u3 on May 31, 2019 at 11:00AM An international workshop on population health intervention research (PHIR) was organized to foster exchanges between experts from different disciplines and different fields.
from Health Economics Review at http://bit.ly/2YZ7BSd on May 31, 2019 at 11:00AM The National Institutes of Health estimates the prevalence of insomnia in menopausal women at 40–50%. Some studies have shown that acupuncture might be effective in treating primary insomnia and insomnia relat…
from Health Economics Review at http://bit.ly/2wuoYhR on May 31, 2019 at 11:00AM Improving efficiencies in clinical research is crucial to translation of findings into practice and delivery of effective, patient-centered health care. This paper describes a project that monitored pragmatic …
from Google Alert at http://bit.ly/2Ieyawi on May 31, 2019 at 05:29AM Alexander Marshall,1 Kiran Gupta,1 Michael Pazirandeh,1 Machaon Bonafede,2 Donna McMorrow2 1Health Economics and Outcomes Research, …
from Healthcare Economist at http://bit.ly/2YV0Il5 on May 31, 2019 at 05:27AM HEOR in 2020: Gazing into the crystal ball. Self-assessed unmet need. Hospital consolidation and patient satisfaction. Which countries oppose WHO drug price transparency proposals? Is bundled payment the future?
from Centre for Applied Health Economics at http://bit.ly/2Id2EhW on May 31, 2019 at 05:04AM A number of Centre for Applied Health Economics staff including Professor Paul Scuffham, Dr Haitham Tuffaha, Associate Professor Martin Downes, Dr Son Nghiem, Dr Clifford Afoakwah and Dr Annick Maujean, are assisting to meet the increasing demand for quantitative and analytical skills of […]
from Google Alert at http://bit.ly/2WtumAp on May 31, 2019 at 02:10AM … "enhance client business decisions related to forecasting, marketing, commercial analytics, business intelligence, health economics, medical affairs, …
from Google Alert at http://bit.ly/2Kdxee8 on May 31, 2019 at 02:10AM … commercial analytics, business intelligence, health economics, medical affairs, strategy and licensing. For more information, visit http://bit.ly/2Idn8av.
from Health and Quality of Life Outcomes at http://bit.ly/2QFAD6I on May 31, 2019 at 02:06AM Workplace violence (WPV) is a global public health problem and has caused a serious threat to the physical and mental health of healthcare workers. Moreover, WPV also has an adverse effect on the workplace beh…
from Health and Quality of Life Outcomes at http://bit.ly/2ws0hlY on May 31, 2019 at 01:36AM As the overdose crisis in North America continues to deepen, public health leaders find themselves responding to sensational media stories, many of which carry forms and themes that mark them as urban legends.
from Health and Quality of Life Outcomes at http://bit.ly/2YYOuYI on May 31, 2019 at 01:36AM Thermal fogging of Insecticides is a vector control strategy used by the Medellin Secretary of Health to combat dengue. This method is employed during outbreaks to curb populations of potentially infectious ad…
from Health and Quality of Life Outcomes at http://bit.ly/2wvyxwM on May 31, 2019 at 01:36AM The Social Engagement Framework for Addressing the Chronic-disease-challenge (SEFAC) project intends to empower citizens at risk of or with type 2 diabetes (T2DM) and/or cardiovascular disease (CVD) to self-ma…
from Health and Quality of Life Outcomes at http://bit.ly/2YYOnwg on May 31, 2019 at 01:36AM The slope (SII) and relative (RII) indices of inequality are commonly recommended to monitor health inequality policies. As an upwards shift of the educational level distribution (ELD) can be part of those pol…
from Health and Quality of Life Outcomes at http://bit.ly/2ww0u7U on May 31, 2019 at 01:36AM China has the largest obese population in the world, and the prevalence of central obesity is increasing dramatically in China. Moreover, the rapid economic growth of China in recent decades has led to rapid u…
from RAND Research Topic: Health and Health Care at http://bit.ly/2Z3q4xj on May 30, 2019 at 11:12PM DG CONNECT commissioned RAND Europe, Open Evidence and BDI Research to undertake the third eHealth benchmarking study, which measured the availability and use of eHealth by general practitioners (GPs) in 27 EU member states, and compared the results to […]
from The Incidental Economist at http://bit.ly/2Xp3E8Y on May 30, 2019 at 09:04PM Below are AcademyHealth Annual Research Meeting posters and sessions involving my colleagues at Harvard T.H. Chan School of Public health. (This is the second of two posts on this theme. Here’s the other.) Sunday, June 2 12:15pm ET Poster Session Irini Papanicolas: NHS […]
from RAND Research Topic: Health and Health Care at http://bit.ly/2HP7qU9 on May 30, 2019 at 07:10PM DG CONNECT commissioned RAND Europe, Open Evidence and BDI Research to undertake the third eHealth benchmarking study, which measured the availability and use of eHealth by general practitioners (GPs) in 27 EU member states, and compared the results to […]
from Amanda Glassman at http://bit.ly/2EJ8XZV on May 30, 2019 at 06:33PM May 30, 2019 Health Taxes to Save Lives: Colombia Version Pamela Gongora-Salazar, a former ministry of health official in Colombia, shares her account of how health taxes happen (or don’t) in the real world. Amanda Glassman
from AcademyHealth Blog at http://bit.ly/2WhzcBt on May 30, 2019 at 06:14PM Entrance Points – the Easy Way to Build Meaningful Connections through Networking at AcademyHealth’s #ARM19 We are just days away from the start of our 2019 Annual Research Meeting (ARM)! The chance to meet with your peers and increase your professional network is almost […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HIUtee on May 30, 2019 at 04:25PM Spending on drugs used to treat cancer patients hit almost $150 billion last year, according to a new report from IQVIA, a 12.9 percent increase from the previous year and the fifth year in a row of double-digit spending growth. The […]
Health Econ Bot 
You must be logged in to post a comment.